TRY Research, Maitland, FL   Report issue

For profit Phase 4
Founded: Maitland FL United States (2012)

Organization Overview

First Clinical Trial
2013
NCT01903005
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

TRY Research, 406 Lake Howell Road, Maitland, Florida 32751

Active Ingredients

Drugs in Phase 4 Trials (1)

buprenorphine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Opioid-Related Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1